ARVN
Price
$27.12
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
One day until earnings call
KYMR
Price
$49.08
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
2 days until earnings call
Ad is loading...

ARVN vs KYMR

Header iconARVN vs KYMR Comparison
Open Charts ARVN vs KYMRBanner chart's image
Arvinas
Price$27.12
Change-$0.00 (-0.00%)
Volume$887.41K
CapitalizationN/A
Kymera Therapeutics
Price$49.08
Change-$0.00 (-0.00%)
Volume$324.18K
CapitalizationN/A
View a ticker or compare two or three
ARVN vs KYMR Comparison Chart
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ARVN vs. KYMR commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Buy and KYMR is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ARVN: $27.12 vs. KYMR: $49.08)
Brand notoriety: ARVN and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 145% vs. KYMR: 82%
Market capitalization -- ARVN: $1.69B vs. KYMR: $3.14B
ARVN [@Biotechnology] is valued at $1.69B. KYMR’s [@Biotechnology] market capitalization is $3.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 6 TA indicator(s) are bullish while KYMR’s TA Score has 8 bullish TA indicator(s).

  • ARVN’s TA Score: 6 bullish, 4 bearish.
  • KYMR’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than ARVN.

Price Growth

ARVN (@Biotechnology) experienced а +5.28% price change this week, while KYMR (@Biotechnology) price change was +5.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ARVN is expected to report earnings on Mar 03, 2025.

KYMR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.15B) has a higher market cap than ARVN($1.69B). KYMR YTD gains are higher at: 92.773 vs. ARVN (-34.111). KYMR has higher annual earnings (EBITDA): -152.44M vs. ARVN (-364.2M). ARVN has more cash in the bank: 1.23B vs. KYMR (510M). ARVN has less debt than KYMR: ARVN (2.1M) vs KYMR (88.2M). ARVN has higher revenues than KYMR: ARVN (93.3M) vs KYMR (88.6M).
ARVNKYMRARVN / KYMR
Capitalization1.69B3.15B54%
EBITDA-364.2M-152.44M239%
Gain YTD-34.11192.773-37%
P/E RatioN/AN/A-
Revenue93.3M88.6M105%
Total Cash1.23B510M241%
Total Debt2.1M88.2M2%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNKYMR
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
81%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 20 days ago
80%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 6 days ago
77%
View a ticker or compare two or three
Ad is loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with ABCL. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
+4.63%
ABCL - ARVN
55%
Loosely correlated
+6.25%
IPSC - ARVN
50%
Loosely correlated
+0.72%
CRBU - ARVN
49%
Loosely correlated
+6.21%
KYMR - ARVN
47%
Loosely correlated
+2.27%
AXON - ARVN
46%
Loosely correlated
+0.06%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with RXRX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+2.27%
RXRX - KYMR
51%
Loosely correlated
+6.02%
CRSP - KYMR
51%
Loosely correlated
+4.96%
RVMD - KYMR
50%
Loosely correlated
+2.87%
BEAM - KYMR
49%
Loosely correlated
+3.71%
RCKT - KYMR
47%
Loosely correlated
+2.64%
More